Keyi Fan

Keyi Fan

Auto-generated profile, based on publicly available information

Keyi Fan

Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
HWHeng Wang
Heng Wang
KFKeyi Fan
Keyi Fan
YNYijie Ning
Yijie Ning
YLYaling Li
Yaling Li
XQXiaotong Qi
Xiaotong Qi
GZGuoping Zheng
Guoping Zheng
Background: Chronic kidney disease is a major global health concern, with type 2 diabetic nephropathy (T2DN) significantly contributing to its burden. This study examines global trends, key risk factors, and clinical characteristics of T2DN to identify modifiable contributors and inform precision management. Methods: Data from the 2021 GBD Study, Mendelian randomization (MR) analyses, NHANES, and a clinical cohort were utilized. Trends in prevalence, incidence, mortality, disability-adjusted life years (DALYs), and population-attributable fractions (PAF) of T2DN risk factors were analyzed globally and across sociodemographic strata. Genetic determinants were identified via two-sample and multivariable MR, while clinical data were analyzed using regression and correlation analyses. Results: Between 1990 and 2021, T2DN prevalence, incidence, and DALYs increased globally, and the global mortality rate rose from 5.73 (4.81, 6.83) to 10.25 (8.62, 12.15). High fasting plasma glucose was the primary risk factor, with rising PAFs for high BMI and systolic blood pressure (SBP), and the global PAF for deaths due to T2DN attributed to high fasting plasma glucose increased from 0.80 to 0.90. MR analysis confirmed causal links between fasting glucose (β = 1.351, P = 2.78e− 4), insulin (β = 2.543, P = 1.20e− 5), T2DM (OR = 2.280, P = 4.14e− 29) and T2DN risk, with BMI and SBP influencing disease progression. NHANES data showed BP’s impact on renal function. A diagnostic model incorporating age, categorical blood pressure data, history of heart failure, and history of stroke was developed, with an AUC of 0.716. In the clinical cohort, T2DN correlated with elevated urinary albumin-to-creatinine ratio, serum creatinine, BP, and BMI variations. Conclusion: T2DM progression to T2DN is driven by hyperglycemia, BMI, and BP, highlighting the need for targeted interventions.

1 February 2026 in Vascular Health and Risk Management
Verified
Journal Article
Open access
HWHeng Wang
Heng Wang
SWShule Wang
Shule Wang
KFKeyi Fan
Keyi Fan
YLYaling Li
Yaling Li
ZWZiyan Wang
Ziyan Wang
GZGuoping Zheng
Guoping Zheng
Aortic dissection (AD) is a life-threatening aortic emergency that progresses rapidly and carries a high mortality rate. We characterised contemporary patterns and long-term trends in AD mortality in the United States and examined associations between ambient temperature and AD mortality. We obtained mortality data for AD from United States CDC WONDER for 1999–2023 and calculated age-adjusted mortality rates (AAMR). Temporal trends were assessed using Joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC). Monthly air temperature data for the period 1999–2023 were obtained from the North America Land Data Assimilation System (NLDAS). Associations between temperature and AD mortality were evaluated across census regions using correlation analyses and Poisson regression models. To explore the future burden, subgroup-specific time series models (ARIMA or ETS) were applied to generate 20-year forecasts. In 2023, there were 4,418 AD deaths (AAMR 1.73 per 100,000; 95% CI 1.68–1.78); rates were highest in the Midwest (1.96), in male (2.19 vs 1.24 in female), in non-Hispanic Black individuals (2.75), and in adults ≥85 years (11.67). From 1999–2023, 86,943 deaths occurred and the overall AAMR declined (AAPC −0.37), but reversed to sustained increases after 2013. Across the four census regions, the monthly AAMR was lowest in summer and highest in winter during 1999–2023 (P < 0.05). A 10°F increase in temperature was associated with lower mortality risk (eg, South RR 0.889). AD mortality has rebounded since 2013 with marked demographic and regional disparities. Lower temperatures and greater thermal variability are linked to higher mortality, supporting seasonally and region-tailored prevention and health-system preparedness.

25 October 2025 in Critical Public Health
Verified
Journal Article
Open access
KFKeyi Fan
Keyi Fan
HWHeng Wang
Heng Wang
YLYaling Li
Yaling Li
ZWZiyan Wang
Ziyan Wang
YSYongbin Shi
Yongbin Shi
HDHonglin Dong
Honglin Dong

1 March 2026 in Vascular Health and Risk Management
Verified
Journal Article
Open access
PDF file
HWHeng Wang
Heng Wang
KFKeyi Fan
Keyi Fan
YLYaling Li
Yaling Li
ZWZiyan Wang
Ziyan Wang
SWShule Wang
Shule Wang
GZGuoping Zheng
Guoping Zheng
Introduction: Pan-arterial diseases, including atherosclerosis (AS), aortic aneurysm and dissection (AAD), and peripheral arterial disease (PAD), impose a substantial global health burden. Although ambient temperature has been implicated in individual arterial conditions, its association with mortality across the pan-arterial spectrum remains incompletely understood. Objective: To evaluate the association between ambient temperature and mortality from pan-arterial diseases across the United States. Methods: We analysed mortality data for adults aged ≥ 25 years with AS, AAD, or PAD in the United States CDC WONDER database from 1999 to 2023. Age-adjusted mortality rates (AAMR) and average annual percent change (AAPC) were estimated. Monthly air-temperature metrics (1999– 2023) were linked at the United States Census region level. Seasonal variation was assessed using analysis of variance. Associations between temperature and mortality were examined using Spearman correlation, Poisson regression with lag structures, and distributed lag non-linear models (DLNM), with results expressed as relative risks (RR) per 10°F increase in temperature. Results: Between 1999 and 2023, AAMRs declined for AS, AAD, and PAD, yet mortality burden remained substantial. Mortality from all three conditions was consistently higher in winter than in summer across Census regions. Monthly mean temperature was inversely correlated with crude mortality for pan-arterial diseases (P < 0.05). In the Northeast, cumulative RR per +10°F across lags 0– 3 months was 0.919 for AS, 0.945 for AAD, and 0.953 for PAD, with similar patterns observed in other regions. DLNM analyses demonstrated a predominantly cold-related excess risk, with acute effects and regional heterogeneity at higher temperatures. Conclusion: Lower ambient temperatures are associated with increased mortality from pan-arterial diseases in the United States. These findings highlight shared vulnerability to cold exposure across arterial diseases and support winter-focused preventive and healthcare preparedness strategies.

9 August 2026 in Bioengineering & Translational Medicine
Verified
Journal Article
Open access
PDF file
RZRuijing Zhang
Ruijing Zhang
YZYuhang Zhang
Yuhang Zhang
CLChuanlong Lu
Chuanlong Lu
KFKeyi Fan
Keyi Fan
HWHeng Wang
Heng Wang
HDHonglin Dong
Honglin Dong
Chronic kidney disease (CKD) has become one of the major diseases threatening global health, with its increasing incidence and mortality rates. Early identification of chronic kidney disease is crucial for accurate disease staging, timely intervention, and improved prognosis. However, the commonly used clinical diagnostic indicators, such as creatinine, albumin level and glomerular filtration rate, can only identify advanced CKD. Imaging examinations, such as computed tomography and magnetic resonance imaging, have limitations such as high costs and high risk of complications, and are not suitable for large‐scale screening of high‐risk populations. Renal biopsy is the gold standard for diagnosing renal fibrosis, but it is invasive. Previous studies have shown that capillary rarefaction is an early event of renal fibrosis, occurring earlier than tubular atrophy and interstitial collagen deposition. However, there is a lack of a minimally invasive, low‐cost, high‐resolution, dynamic and real‐time monitoring method for renal microcirculation that is suitable for large‐scale screening. There is an urgent need for reliable methods to screen early‐stage CKD patients. In this study, we have for the first time combined real‐time and wide‐field laser speckle imaging (RFLSI), near‐infrared II imaging (NIR‐II), duplex ultrasound (DUS) and Contrast‐Enhanced Ultrasound (CEUS) to monitor vascular changes and evaluate the progression of renal fibrosis. The combination of four imaging methods enabled the early monitoring of CKD progression by monitoring microcirculation. Among them, CEUS can detect changes in the renal microcirculation at the early stage of renal fibrosis, even earlier than the pathological damage of the kidneys. Through visualization and quantification of the progression of renal fibrosis and validation through histopathology, this study utilizes preclinical imaging to supplement clinical imaging of renal fibrosis, providing a more comprehensive method for monitoring microcirculation, which is helpful for guiding clinical decisions and providing insights into disease progression.

19 January 2023 in Research Square
Verified
Preprint
Open access
PDF file
YZYao-Chen Zhang
Yao-Chen Zhang
KFKeyi Fan
Keyi Fan
QWQi Wang
Qi Wang
JHJing-Xi Hu
Jing-Xi Hu
QWQian Wang
Qian Wang
SZsheng xiao zhang
sheng xiao zhang
Background Observational studies have reported an association between circulating levels of mammalian target of rapamycin (mTOR)-dependent circulating proteins and multiple sclerosis (MS). However, the casual association has not been fully elucidated. Mendelian randomization (MR) is used to overcome limitations inherent to observational studies and assess the causal association. Methods To explore the causal association between mTOR-dependent proteins (AKT, RP-S6K, eIF4E-BP, eIF4A, eIF4E, eIF4G, and PKC-α) and MS, summary statistics were obtained from GWAS meta-analysis of the International Multiple Sclerosis Genetics Consortium (47429 patients and 68374 controls) and the INTERVAL study (genetic associations with 2994 plasma proteins from 3301 healthy individuals). MR analysis and sensitivity analyses were conducted. Results Among seven selected mTOR-dependent proteins, the circulating level of PKC-α (OR = 0.90, 95%CI 0.82–0.98, P = 0.017) and RP-S6K (OR = 1.12, 95%CI 1.00-1.25, P = 0.045) were associated with MS risk, while no significant causation was found between other proteins (AKT, eIF4E-BP, eIF4A, eIF4E, eIF4G) and MS. Conclusion Molecules in the mTOR signaling pathway may bidirectionally regulate the occurrence and development of MS. PKC-α is a protective factor, while RP-S6K is a risk factor. They might be used as future therapeutic targets for screening high-risk individuals.